Huawei Watch D3: What the Indonesian Certification Reveals

What the SDPPI listing tells us

The Indonesian certification is meaningful because it suggests Huawei is preparing at least two related wireless-device configurations for a market launch. The listed model numbers are:

• RIV-B10
• RIV-B11

However, the available reporting does not establish how the two versions differ. They could represent regional or radio configurations, different case or strap options, or other hardware variations. Those possibilities should not be treated as confirmed specifications. The listing does not reveal the Watch D3’s design, connectivity, sizes, battery, health sensors, or pricing.

The certification also does not prove that Huawei will use the Watch D3 name globally. That name is widely reported in connection with the listing, but Huawei has not yet published an official product page or specification sheet.

Could the Watch D3 launch on September 2?

Huawei has confirmed an “Innovative Product Launch” in Munich on September 2, 2026, using the “Chase the Wild” slogan. The teaser points toward wearables, and several reports expect the international debut of the Watch GT 7 and Watch GT 7 Pro, which had already appeared in China.

The timing makes Munich a logical venue for the Watch D3 as well. Certification activity has appeared shortly before the event, and earlier reporting had placed the medical wearable in a September launch window. Still, there is an important distinction between a reasonable inference and a company confirmation: Huawei has not said that the Watch D3 will be shown in Munich, nor has it confirmed a release date or launch markets.

The likely health focus: blood-pressure monitoring

The Watch D line’s defining feature is its dedicated inflatable cuff or airbag mechanism integrated into the strap for blood-pressure measurements. That approach is different from watches that rely only on optical sensors and software estimates. Reporting on the Watch D2 describes it as one of the few mainstream smartwatches using a dedicated cuff for on-device blood-pressure monitoring.

If the Watch D3 is a genuine D2 successor, retaining that hardware would be the most logical product-direction expectation. It would also preserve the feature that most clearly separates the Watch D family from mainstream Apple, Samsung, and Google smartwatch offerings described in the available reporting.

That does not establish that the D3 will be more accurate, medically cleared in every market, or suitable for diagnosis. Those questions require official specifications, regulatory documentation, and independent testing. None of those details has been provided for the D3 so far.

What might improve over the Watch D2?

The most plausible improvements are physical and practical rather than confirmed features. A future D3 could refine the cuff and strap, reduce the watch’s bulk, improve comfort, extend battery life, or add health-related software. These are expectations based on the product’s purpose and predecessor—not published D3 specifications.

Some online reports also mention new health capabilities, including glucose-related functions. The available material does not provide reliable official confirmation of those claims. In particular, “risk assessment” should not be presented as the same thing as non-invasive blood-glucose measurement or diabetes diagnosis. Until Huawei explains the feature and its regulatory status, it is safer to treat such reports as unverified.

The same caution applies to claims about a specific slimmer redesign, display size, colors, operating system, or price. No dependable D3 specification sheet is currently available in the supplied evidence.

How the D3 fits Huawei’s 2026 product calendar

Huawei’s autumn schedule already includes several significant events, but they are not interchangeable:

• The nova 16 family launched in China on June 1, 2026.
• Huawei introduced the nova 16 SE in China on August 5, 2026.
• The company’s global Munich event is scheduled for September 2, 2026, with the product lineup still undisclosed.
• HUAWEI CONNECT 2026 is scheduled for September 17–19 in Shanghai and is centered on enterprise technology and AI infrastructure, making it an unlikely primary venue for a consumer smartwatch launch.

This calendar supports the idea that Huawei has an active second-half product cycle, but it does not independently confirm the Watch D3’s launch date or market availability.

Bottom line

The strongest current conclusion is that Huawei appears to be preparing a new blood-pressure-focused smartwatch, and the RIV-B10 and RIV-B11 SDPPI listings make the Watch D3 rumor more credible. The two model numbers confirm neither two retail editions nor any specific hardware difference.

September 2 in Munich is a plausible unveiling date because Huawei has confirmed a major global wearable-oriented event, but the Watch D3 is not part of the official announcement yet. Until Huawei publishes product materials, the key unanswered questions remain its design, cuff technology, health features, regulatory clearances, price, and country-by-country availability.